Clark W Lloyd

🇴🇲 California Retina Consultants

OpenAlex2 articles in GJC

2 articles in GJC

Efficacy and Safety of Intravitreal Sirolimus for Noninfectious Uveitis of the Posterior Segment: Results from the Sirolimus Study Assessing Double-Masked Uveitis Treatment (SAKURA) Program.

Merrill Pauline T, Clark W Lloyd, Banker Alay S, Fardeau Christine, Franco Pablo, LeHoang Phuc et al.

OphthalmologyApr 202029 citationsRandomized Controlled Trial

Intravitreal sirolimus (440 μg) effectively reduced inflammation in noninfectious posterior uveitis with good safety and minimal IOP impact, offering a new treatment option.

Full abstract PubMed

Intravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion: 1-year results from the phase 3 COPERNICUS study.

Brown David M, Heier Jeffrey S, Clark W Lloyd, Boyer David S, Vitti Robert, Berliner Alyson J et al.

Am J OphthalmolMar 20130 citationsRandomized Controlled Trial

Intravitreal aflibercept significantly improved vision in CRVO-related macular edema, with benefits maintained at one year with PRN dosing, offering an effective treatment option.

Full abstract PubMed

All 2 articles loaded

Global Search

Clark W Lloyd

Efficacy and Safety of Intravitreal Sirolimus for Noninfectious Uveitis of the Posterior Segment: Results from the Sirolimus Study Assessing Double-Masked Uveitis Treatment (SAKURA) Program.

Intravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion: 1-year results from the phase 3 COPERNICUS study.